简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
概要:Here's how Allergan went from its start as a sleepy but beloved company out of Southern California in the 1950s to an acquisition target for AbbVie.
AbbVie is acquiring Botox-maker Allergan in a $63 billion deal, the companies said Tuesday.
Allergan has had a long history dating back to the 1940s. Over the years it's gone through major acquisitions, including some that have fallen through.
Visit Business Insider's homepage for more stories.
Allergan, the pharmaceutical company best known for making Botox, on Tuesday agreed to be acquired by AbbVie in a $63 billion deal.
Investors had been unhappy with Allergan's stock performance over the last year, and some have been vocal in calling for change.
Here's how the company went from its start as a small but beloved company out of Southern California in the 1950s to the latest takeover target.
This article was initially published in June 2018 and has been updated.
免責事項:
このコンテンツの見解は筆者個人的な見解を示すものに過ぎず、当社の投資アドバイスではありません。当サイトは、記事情報の正確性、完全性、適時性を保証するものではなく、情報の使用または関連コンテンツにより生じた、いかなる損失に対しても責任は負いません。